-
1
Membranoproliferative Glomerulonephritis following the Oxford AstraZeneca COVID-19 Vaccine
Published 2021-01-01Get full text
Article -
2
Immunogenicity of Oxford-AstraZeneca COVID-19 vaccine in Vietnamese healthcare workers
Published 2021“…At month 3, neutralizing antibodies decreased and 94.7% (89 of 94) of the study participants remained seropositive. The Oxford-AstraZeneca COVID-19 vaccine is immunogenic in Vietnamese health-care workers. …”
Journal article -
3
Immunogenicity of Oxford-AstraZeneca COVID-19 vaccine in Vietnamese health-care workers
Published 2022“…At month 3, neutralizing antibodies decreased and 94.7% (89 of 94) of the study participants remained seropositive. The Oxford-AstraZeneca COVID-19 vaccine is immunogenic in Vietnamese health-care workers. …”
Journal article -
4
Adverse effects of Oxford-AstraZeneca COVID-19 vaccine among Egyptian healthcare workers
Published 2022-10-01Get full text
Article -
5
Rhabdomyolysis following Oxford/AstraZeneca COVID-19 vaccination; two case reports from Iran
Published 2024-01-01“…The present study intended to report two cases of rhabdomyolysis due to vaccination with Oxford/AstraZeneca COVID-19 vaccines. The patients were two men aged 70 and 75 years old who presented to a healthcare facility with weakness, myalgia, nausea, and vomiting for about ten days after receiving their first dose of the Oxford/AstraZeneca COVID-19 vaccine. …”
Get full text
Article -
6
-
7
A case of acute tubulointerstitial nephritis following administration of the Oxford-AstraZeneca COVID-19 vaccine: a case report
Published 2023-03-01“…Conclusions To our knowledge, this was the first described case of acute tubulointerstitial nephritis following administration of the Oxford-AstraZeneca COVID-19 vaccine, although a number of cases have emerged more recently. …”
Get full text
Article -
8
-
9
ANCA-associated vasculitis following Oxford-AstraZeneca COVID-19 vaccine in Brazil: Is there a causal relationship? A case report
Published 2022-10-01“…This article presents a case of rapidly progressive glomerulonephritis following the Oxford-AstraZeneca COVID-19 vaccine in a female patient 58 years old. …”
Get full text
Article -
10
-
11
-
12
Prospective Evaluation of Side-Effects Following the First Dose of Oxford/AstraZeneca COVID-19 Vaccine among Healthcare Workers in Saudi Arabia
Published 2022-01-01“…Conclusions: Findings of the present study support the safety of the Oxford/AstraZeneca COVID-19 vaccine among HCWs in Saudi Arabia. …”
Get full text
Article -
13
-
14
Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database
Published 2021-11-01“…A retrospective descriptive analysis was conducted of spontaneous reports for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 vaccines submitted to the EudraVigilance database in the period from 17 February to 14 June 2021. …”
Get full text
Article -
15
Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study
Published 2022-07-01“…Healthcare workers were the priority population that received the Oxford AstraZeneca COVID-19 vaccine. However, there was no nationwide study on the safety of the vaccine in Ethiopia. …”
Get full text
Article -
16
-
17
-
18
-
19
Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study
Published 2022-06-01Subjects: Get full text
Article -
20
Cerebral venous sinus thrombosis following intracerebral hemorrhage after COVID‐19 AstraZeneca vaccination: A case report
Published 2022-11-01Subjects: Get full text
Article